triparanol has been researched along with metyrapone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Nagano, T | 1 |
Dean, PD; Whitehouse, MW | 1 |
Siegenthaler, W; Werning, C | 1 |
HOFFMEISTER, W | 1 |
5 other study(ies) available for triparanol and metyrapone
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
[Urinary excretion of pregnanetriol in various internal diseases].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Child; Child, Preschool; Endocrine System Diseases; Female; Humans; Hypertension; Liver Cirrhosis; Male; Metyrapone; Middle Aged; Paramethasone; Pregnanetriol; Triparanol | 1966 |
The effects of mepyrapone (SU 4885) and some hypercholesterolaemic drugs on hepatic sterol and fatty acid oxidation.
Topics: Animals; Anticholesteremic Agents; Carnitine; Cattle; Cholesterol; Drug Antagonism; Fatty Acids; Female; Liver; Male; Metyrapone; Mice; Mitochondria; Myocardium; NAD; Oxidation-Reduction; Oxidoreductases; Proadifen; Pyridines; Rats; Sterols; Triparanol | 1967 |
[Therapy of secondary hyperaldosteronism].
Topics: Aminoglutethimide; Butanones; Heparin; Humans; Hyperaldosteronism; Metyrapone; Mineralocorticoid Receptor Antagonists; Spironolactone; Triamterene; Triparanol | 1973 |
[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
Topics: Adrenocorticotropic Hormone; Aldosterone; Ascites; Body Fluids; Classification; Dexamethasone; Extracellular Space; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Kidney Tubules; Liver Cirrhosis; Metyrapone; Mineralocorticoid Receptor Antagonists; Natriuresis; Nephrotic Syndrome; Pathology; Pharmacology; Physiology; Potassium; Sodium; Spironolactone; Toxicology; Triparanol | 1964 |